Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17466Investigational
UCART22 are allogeneic CD22-specific universal CAR-expressing T lymphocytes.
- Mechanism
- Curator reviewed
Pharmacologically active on B-cell receptor CD22
- Also known as
- Allogeneic gene-edited CAR T cells UCART22 · Allogeneic TALEN gene-edited CAR T-Cells UCART22 · Allogenic engineered T cells expressing anti-CD22 CAR UCART22
- Code names
- UCART-22
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with UCART22, and which of those have an active Phase 3 trial?